Abbott Laboratories (ABT)

NYSE · Healthcare · Medical Devices
$109.29-1.06%As of 2026-11-12 · USD
Last session low $109.00Last session high $110.33
52-week low $81.9752-week high $132.03
Market cap
$189.28B
Sector
Healthcare
P/E (TTM)
40.8x
Dividend yield
2.31%
Next earnings
2027-01-28 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-11 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)56.3In the neutral range (30 to 70)
MACD (12, 26, 9)2.23Above its signal line (1.82); histogram 0.41
Bollinger %B (20, 2)66%Inside the bands (98.59 to 114.72)
SMA 20106.65Price is 2.5% above
SMA 50103.98Price is 5.1% above
SMA 200100.96Price is 8.3% above
ATR (20)2.62% of priceAverage true range per day
52-week position55%In the middle of the 81.97 to 132.03 range

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

Insider filings, 90 daysNo purchases and 2 sales (about $46.2M).
Latest fiscal yearEnded 2025-12-31: revenue of $44.33B and an operating margin of 18.2%.
Next earnings reportExpected on 2027-01-28 (the date is an estimate).

More in Medical Devices